Stroke Trial, Recruiting NCT06711432 Sponsor: Zhejiang Cancer Hospital Condition: Stroke
Back to Stroke

Stroke Trial, Recruiting

NCT06711432
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been identified as high-risk for stroke, meaning they have 3 or more stroke risk factors according to a stroke risk screening tool
  • People who are scheduled to have surgery under general anaesthesia to remove or treat an abdominal tumour (such as gynaecological, urinary, liver, bile duct, or digestive system tumours), where the surgery is expected to last more than 2 hours
  • People whose overall health before surgery has been rated as Class II or III on a standard anaesthesia fitness scale (confirm with trial site)
  • People who have had a blood pressure monitoring line (a thin tube placed into an artery) inserted before surgery, and who have signed a consent form agreeing to take part

Who may not be able to join:

  • People who do not wish to take part in the study
  • People with serious heart conditions, such as severe heart valve disease, sick sinus syndrome, or a significant blockage in the heart's electrical system without a pacemaker fitted
  • People with severe liver disease, classified as Child-Pugh class C (the most serious level of liver function impairment)
  • People who currently need kidney replacement therapy, such as dialysis
  • People who have had a stroke within the past 3 months
  • People who require emergency surgery
  • People with a pre-existing history of mental illness, epilepsy, Parkinson's disease, or myasthenia gravis
  • People with difficulties in speaking, seeing, or hearing that would prevent them from completing a cognitive (thinking and memory) assessment
  • People for whom carefully controlled blood pressure management during surgery would not be appropriate, such as those who need deliberately lowered blood pressure during their procedure

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 21 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: +8618758096745

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Zhejiang Cancer Hospital
Registry
ClinicalTrials.gov
Start date
18 September 2024
Est. completion
1 May 2026

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Postoperative delirium and cognitive function in patients with high-risk stroke.

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 21 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov